Silexion Therapeutics (NASDAQ: SLXN) is advancing precision oncology with a focus on KRAS-driven cancers, among the most challenging targets in oncology. In collaboration with Evonik, Silexion has ...
Silexion Therapeutics Corp. (NASDAQ:SLXN) stock is trading higher on Tuesday with a strong session volume of 36.4 million versus the average volume of 2.65 as per data from Benzinga Pro. Silexion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback